Table 2 Measures over time for treatment and waitlist control group

IES-R

Avoidence

  NET

17.64

9.19

9.09

5.43

8.45

5.22

9.73

6.20

  WL

15.73

4.08

16.09

3.65

9.36

2.98

8.46

3.30

Intrusion

  NET

16.91

6.88

8.73

4.56

8.36

3.91

7.73

5.10

  WL

17.36

3.17

16.00

4.29

9.00

3.55

8.55

2.77

Hyperarousal

  NET

13.64

4.48

8.00

3.82

7.72

4.13

6.64

4.39

  WL

14.55

3.59

15.09

2.98

9.91

2.88

8.55

2.54

GHQ-28

  NET

9.45

5.05

3.00

3.38

2.82

3.63

2.73

3.35

  WL

13.27

6.94

13.64

5.75

5.55

3.45

5.09

2.70

HADS

Anxiety

  NET

8.45

3.86

5.27

2.83

5.00

2.53

5.45

3.03

  WL

9.55

4.91

8.64

3.56

5.00

3.16

4.82

2.48

Depression

  NET

8.18

4.21

4.18

2.36

5.00

2.68

4.91

3.02

  WL

7.09

3.21

7.09

2.95

4.00

2.24

3.73

2.10

CiOQ

Positive

  NET

24.82

3.66

26.91

2.43

27.45

2.11

28.00

1.79

  WL

26.82

2.27

26.73

2.33

28.27

2.24

28.09

2.12

Negative

  NET

16.55

7.92

11.82

5.78

11.09

6.07

10.64

4.25

  WL

15.00

7.25

15.82

6.84

11.36

5.82

9.90

3.18

MSPSS

  NET

60.64

13.06

62.00

11.57

60.64

10.86

61.27

11.72

  WL

61.00

6.96

58.91

5.77

60.18

9.38

57.55

5.50

SCSQ

Active

  NET

23.45

7.93

25.09

6.77

23.45

6.07

23.82

8.57

  WL

24.18

5.96

23.09

5.39

24.73

4.08

24.18

5.10

Passive

  NET

11.18

4.29

10.27

3.23

10.45

3.45

10.09

2.84

  WL

11.45

2.58

11.73

2.97

10.82

2.96

10.45

1.57